For the full text of Professor Towse's remarks, visit OHE News on the OHE website.

1. ISPOR 2014 - 2015 President Elect
Adrian Towse, MA, MPhil
Office of Health Economics
London, UK
Incoming
Presidential Address

2. 1. Continuing to globalise
2. Responding to growing payer demand for
evidence of value
3. Continuing to raise HEOR scientific
standards
4. Supporting the next generation of
researchers.
Challenges facing ISPOR

3. • Globalisation of ISPOR has to be linked to an understanding of
decision making in emerging country health systems
• There is growing desire in low and middle income countries to
achieve universal health coverage (UHC) for their populations
• Using HTA to support priority setting as part of UHC will be
important
• A key question in HTA will be the potential transferability of
evidence (its ‘public good’ characteristics)
• But so will creating incentives in health care systems to achieve
better outcomes, and measuring performance
In other words, diverse health systems have different challenges.
ISPOR has to anticipate and respond to these needs
The first challenge: globalisation

4. • Outcomes research is ‘the scientific discipline that evaluates the
effect of health care interventions on patient related if not patient
specific, clinical, humanistic and economic outcomes’
• Health care intervention: ‘a program, policy, measure, or activity
designed to have an impact on an illness or disease in an individual
or a population’
• Health care technology (for HTA) consists of:
– Drugs, biologics, devices, procedures
– Support systems, organisational, delivery and managerial systems
(e.g. disease management programme, health care payment
system)
Source: ISPOR Book of Terms
Break out of narrow perspectives

5. Beijing, China
6-9 September 2014
Early Registration
Deadline:
22 July 2014
ISPOR Meetings

6. Amsterdam,
The Netherlands
8-12 November 2014
Abstract Submission
Deadline:
24 June 2014
MEETINGSISPOR Meetings

7. VIH Co-editors-in–chief
Publications strength
Michael Drummond Dan Mullins

8. VIHRI Co-editors-in–chief
Publications strength
Bong-Min Yang Federico Augustovski Dan Greenberg

9. VIH Impact Factor
projected to be up
30%

10. Upcoming Webinars
Performance-Based Risk-Sharing Arrangements (July)
Budget Impact Analysis II (September)
Assessing the Evidence - Modeling Studies (November)
Assessing the Evidence - Observational Studies
(October)
Assessing the Evidence - Indirect Treatment Comparison
Studies (December)

11. ISPOR Task Force Reports
in Development
Good Practices on:
Cost-Effectiveness Analysis Alongside Clinical Trials
Multi-Criteria Decision Analysis for Health Care Decision
Collecting and Analyzing Utility Data for Economic Models
Modeling Health State Utility Values - Mapping

12. 2014-2016 Directors
President Elect
2014-2015 ISPOR
Board of Directors

13. 2013-2015 Directors
Past President Treasurer
2014-2015 ISPOR
Board of Directors

14. Providing efficient and
effective health care is a
global challenge
ISPOR is a global organisation
that exists to help meet
this challenge
Diverse health systems have different
challenges. ISPOR has to anticipate and
respond to these needs: must break out
of narrow perspectives

15. Thank You!
The full text of Professor Towse’s remarks is available on the OHE blog, OHE News.